2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
Susan M GoodmanBryan D SpringerAntonia F ChenMarshall DavisDavid R FernandezMark FiggieHeather FinlaysonMichael D GeorgeJon T GilesJeremy GilillandBrian KlattRonald MacKenzieKaleb MichaudAndy O MillerLinda RussellAlexander SahMatthew P AbdelBeverly JohnsonLisa A MandlPeter SculcoMarat TurgunbaevAmy S TurnerAdolph YatesJasvinder A SinghPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2022)
This updated guideline includes recently introduced immunosuppressive medications to help decision-making by clinicians and patients regarding perioperative disease-modifying medication management for patients with IA and SLE at the time of elective THA or TKA.
Keyphrases
- total knee arthroplasty
- total hip
- patients undergoing
- end stage renal disease
- decision making
- cardiac surgery
- healthcare
- newly diagnosed
- ejection fraction
- systemic lupus erythematosus
- rheumatoid arthritis
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- adverse drug
- palliative care
- emergency department
- disease activity
- juvenile idiopathic arthritis